“Folate Receptor-Positive Circulating Tumor Cells as Accurate Biomarkers for Colorectal Cancer Diagnosis and Staging”

https://pubmed.ncbi.nlm.nih.gov/38112831

The study found that analyzing folate receptor-positive circulating tumor cells (FR+CTCs) can accurately distinguish colorectal cancer (CRC) from benign colorectal diseases, with excellent diagnostic efficiency in screening CRC, and the potential to predict tumor stage and guide treatment.